|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.840 USD | +5.49% |
|
+1.05% | -66.05% |
| 06-29 | Fulcrum Therapeutics, Inc.(NasdaqGM:FULC) dropped from Russell Small Cap Comp Growth Benchmark | CI |
| 06-29 | Fulcrum Therapeutics, Inc.(NasdaqGM:FULC) dropped from Russell 2500 Growth Benchmark | CI |
| Market Cap | 256M 224M 206M 192M 363M 24.36B 369M 2.47B 959M 11.98B 960M 940M 41.27B | P/E 2026 * |
-5.05x | P/E 2027 * | -6.61x |
|---|---|---|---|---|---|
| Enterprise Value | -48.73M -42.6M -39.15M -36.49M -69.21M -4.64B -70.26M -470M -183M -2.28B -183M -179M -7.86B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
96.17% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Fulcrum Therapeutics, Inc.
| 1 day | +5.49% | ||
| 1 week | +1.05% | ||
| Current month | +4.92% | ||
| 1 month | +4.07% | ||
| 3 months | -52.24% | ||
| 6 months | -64.58% | ||
| Current year | -66.05% |
| 1 week | 3.61 |  | 3.92 |
| 1 month | 3.34 | | 4.02 |
| Current year | 2.83 | | 12.03 |
| 1 year | 2.83 | | 15.74 |
| 3 years | 2.32 | | 15.74 |
| 5 years | 2.25 | | 33.1 |
| 10 years | 2.25 | | 33.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alexander Sapir
CEO | Chief Executive Officer | 59 | 2023-06-30 |
Alan Musso
DFI | Director of Finance/CFO | 64 | 2023-08-06 |
| Chief Tech/Sci/R&D Officer | - | 2021-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Gould
BRD | Director/Board Member | 71 | 2016-07-18 |
James Geraghty
BRD | Director/Board Member | 71 | 2016-07-18 |
Kathryn Haviland
CHM | Chairman | 50 | 2022-01-09 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-29 | Free | Director | 32,000 | 0.0480% | ||
| 06-29 | Free | Director | 32,000 | 0.0480% | ||
| 06-29 | Free | Chairman | 32,000 | 0.0480% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.49% | +1.05% | -44.51% | +13.95% | 256M | |
| +1.70% | +7.41% | +2.50% | +8.18% | 49.92B | |
| +0.92% | +3.93% | +399.71% | +604.02% | 40.23B | |
| +1.89% | +8.32% | +26.06% | -6.27% | 34.55B | |
| +2.38% | +6.35% | +21.25% | +55.45% | 33.09B | |
| +3.96% | +10.67% | +8.30% | +37.95% | 27.51B | |
| +2.51% | +5.27% | - | - | 17.05B | |
| +2.58% | +5.79% | +73.44% | +135.37% | 15.92B | |
| +0.32% | +0.58% | +14.00% | +19.09% | 13.86B | |
| +3.30% | +0.76% | +90.23% | +93.88% | 13.52B | |
| Average | +2.50% | +5.88% | +65.66% | +106.85% | 24.59B | |
| Weighted average by Cap. | +2.07% | +6.53% | +90.05% | +135.73% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -58.87M -51.46M -47.3M -44.09M -83.62M -5.61B -84.89M -568M -221M -2.76B -221M -216M -9.49B | -46.04M -40.25M -36.99M -34.47M -65.39M -4.38B -66.38M -444M -173M -2.15B -173M -169M -7.42B |
| Net Debt | -305M -266M -245M -228M -433M -29B -439M -2.94B -1.14B -14.26B -1.14B -1.12B -49.13B | -296M -259M -238M -222M -421M -28.22B -427M -2.86B -1.11B -13.87B -1.11B -1.09B -47.8B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-02 | US$3.840 | +5.49% | 1,709,759 |
| 26-07-01 | US$3.640 | -0.55% | 1,638,326 |
| 26-06-30 | US$3.660 | -1.88% | 2,423,328 |
| 26-06-29 | US$3.730 | -1.84% | 1,517,069 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- FULC Stock
Select your edition
All financial news and data tailored to specific country editions
